DEA Failed To Explain Rejection Of Psilocybin Waiver To Treat Cancer Patients, Federal Appeals Court Challenge Says - Marijuana Moment
www.marijuanamoment.net
Lawyers for a doctor in Washington State seeking to legally use psilocybin for end-of-life care argue in a new federal appeals court filing that the Drug Enforcement Administration (DEA) failed to explain a key decision when it denied him access to the psychedelic. They’re asking judges to reverse that move, calling it arbitrary and capricious, […]
  • aelwero@lemmy.worldEnglish
    1·
    9 months ago

    DEA pointed to the statutory characteristics of schedule I drugs

    Or in other words… “Because we say so”…

    Psilocybin is an oddity. Its generally considered to be among the “harder” drugs, but afaik, it completely lacks the advanced addictiveness typical of the class. Pretty sure opiates present a much greater threat in that regard, and yet here we are :)

    I can say anecdotally that psilocybin is a wildly effective means to abort a severe migraine episode… Something even the strongest of opiates cannot do.